OFIX
Orthofix Medical Inc.
NASDAQ · USHealthcareMedical - Devices
$11.56-0.17%
Price as of Jul 20, 2026
OFIX financials
Orthofix Medical Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $822.3M | $799.5M | $746.6M | $460.7M |
| Cost of revenue | $270.6M | $253.6M | $260.4M | $123.5M |
| Gross profit | $551.7M | $545.9M | $486.3M | $337.2M |
| Operating expenses | $620.2M | $630.5M | $625.4M | $350.4M |
| Operating income | -$68.5M | -$84.6M | -$139.1M | -$13.3M |
| Net income | -$92.2M | -$126.0M | -$151.4M | -$19.7M |
| EBITDA | -$22.4M | -$34.2M | -$79.5M | $15.7M |
| Basic EPS | $-2.28 | $-3.30 | $-4.12 | $-0.98 |
| Diluted EPS | $-2.28 | $-3.30 | $-4.12 | $-0.98 |
| Balance sheet | ||||
| Cash & equivalents | $82.0M | $83.2M | $33.1M | $50.7M |
| Total assets | $850.6M | $893.3M | $925.3M | $458.6M |
| Total liabilities | $400.6M | $390.2M | $326.6M | $121.8M |
| Stockholders’ equity | $450.0M | $503.1M | $598.7M | $336.9M |
| Total debt | $229.3M | $179.6M | $117.1M | $21.5M |
| Net debt | $147.2M | $96.4M | $84.0M | -$29.2M |
| Cash flow | ||||
| Operating cash flow | $33.3M | $25.8M | -$45.8M | -$11.5M |
| Capital expenditure | -$34.6M | -$34.9M | -$62.0M | -$23.2M |
| Free cash flow | -$1.3M | -$9.1M | -$107.8M | -$34.7M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |